Search
Displaying 301–310 of 857 results
-
SparingVision to Acquire Therapy for Resurrecting Dormant Cones for Vision Restoration
Eye On the Cure Research NewsThe gene-agnostic approach shows promise for people with late-stage RP and related diseases.
-
Ambitious Swimmer Spreading Optimism
Beacon Stories26-year-old Becca is a two-time Paralympic swimmer for Team USA, diagnosed with Usher syndrome type 1 (USH1) at only four years old. But she has never let her diagnosis with Usher syndrome stop her from doing exactly what she puts her mind to.
-
Investing in Cures Summit 2021
Landing PageThe 2021 Investing in Cures Summit (ICS) convenes key stakeholders of the Foundation Fighting Blindness and RD Fund to learn from the world’s leading industry, clinical and retinal science innovators poised to take emerging therapies across the finish line.
-
Investing in Cures Summit 2021
Landing PageThe 2021 Investing in Cures Summit (ICS) convenes key stakeholders of the Foundation Fighting Blindness and RD Fund to learn from the world’s leading industry, clinical and retinal science innovators poised to take emerging therapies across the finish line.
-
Beacon Stories
American Banker dubbed her as “the sharpest mind analyzing banking policy today – maybe ever.”
-
Encouraging Early Report for Three Patients in LCA1-GUCY2D Gene Therapy Clinical Trial
Eye On the Cure Research NewsDevelopment of the emerging gene therapy is being funded by the Foundation’s RD Fund
-
Foundation Invests $5.5 Million in Seven New Translational Research Projects
Eye On the Cure Research NewsProjects target a variety of conditions including: age-related macular degeneration, Stargardt disease, retinitis pigmentosa, and Usher syndrome type 3A
-
Bionic Sight’s Optogenetic Therapy Enables Blind Patients to Detect Light and Motion in Early Trial
Eye On the Cure Research NewsThe approach holds potential for restoring vision to people with little or no vision
-
ProQR’s RNA Therapy for USH2A Performs Well in Phase 1/2 Clinical Trial
Eye On the Cure Research NewsThe company is planning two Phase 2/3 clinical trials for the treatment
-
Foundation Fighting Blindness Launches Chapter Program Rebrand
Press ReleasesThe program honors Lulie Gund and her legacy and commitment to the Foundation’s Chapter community.
.png)
